Pursuant to Regulation 32 of SEBI (LODR) Regulations, 2015, attaching herewith Non-Applicability of Statement of Deviation.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Vivanza Biosciences Ltd has filed a confirmation with BSE stating that the Statement of Deviation or Variation under SEBI Regulation 32 is not applicable to the company. The filing dated 14th April, 2026 confirms that the company has not raised any funds through Public Issue, Rights Issue, Preferential Issue, or Qualified Institutions Placement (QIP). Since no such fundraising occurred, the company is not required to submit a statement of deviation or variation regarding the use of proceeds. The filing was signed by Chaitra Arora, Company Secretary & Compliance Officer.
This is a routine compliance filing with no direct impact on shareholders. It simply confirms that no capital-raising activity has taken place that would require tracking of fund utilisation.